1. Home
  2. BMEA vs TDUP Comparison

BMEA vs TDUP Comparison

Compare BMEA & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • TDUP
  • Stock Information
  • Founded
  • BMEA 2017
  • TDUP 2009
  • Country
  • BMEA United States
  • TDUP United States
  • Employees
  • BMEA N/A
  • TDUP N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • TDUP Catalog/Specialty Distribution
  • Sector
  • BMEA Health Care
  • TDUP Consumer Discretionary
  • Exchange
  • BMEA Nasdaq
  • TDUP Nasdaq
  • Market Cap
  • BMEA 153.3M
  • TDUP 172.9M
  • IPO Year
  • BMEA 2021
  • TDUP 2021
  • Fundamental
  • Price
  • BMEA $4.19
  • TDUP $1.42
  • Analyst Decision
  • BMEA Buy
  • TDUP Buy
  • Analyst Count
  • BMEA 13
  • TDUP 6
  • Target Price
  • BMEA $37.25
  • TDUP $3.40
  • AVG Volume (30 Days)
  • BMEA 1.1M
  • TDUP 712.7K
  • Earning Date
  • BMEA 10-29-2024
  • TDUP 11-04-2024
  • Dividend Yield
  • BMEA N/A
  • TDUP N/A
  • EPS Growth
  • BMEA N/A
  • TDUP N/A
  • EPS
  • BMEA N/A
  • TDUP N/A
  • Revenue
  • BMEA N/A
  • TDUP $313,757,000.00
  • Revenue This Year
  • BMEA N/A
  • TDUP N/A
  • Revenue Next Year
  • BMEA N/A
  • TDUP N/A
  • P/E Ratio
  • BMEA N/A
  • TDUP N/A
  • Revenue Growth
  • BMEA N/A
  • TDUP 0.58
  • 52 Week Low
  • BMEA $3.61
  • TDUP $0.50
  • 52 Week High
  • BMEA $20.21
  • TDUP $2.49
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 24.17
  • TDUP 46.94
  • Support Level
  • BMEA $3.81
  • TDUP $1.31
  • Resistance Level
  • BMEA $6.06
  • TDUP $1.56
  • Average True Range (ATR)
  • BMEA 0.56
  • TDUP 0.13
  • MACD
  • BMEA -0.14
  • TDUP -0.07
  • Stochastic Oscillator
  • BMEA 7.40
  • TDUP 11.54

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About TDUP ThredUp Inc.

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.

Share on Social Networks: